ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

SAN Sanofi

86.03
-0.60 (-0.69%)
Last Updated: 03:26:43
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Sanofi SAN Euronext Ordinary Share
  Price Change Price Change % Share Price Last Trade
-0.60 -0.69% 86.03 03:26:43
Open Price Low Price High Price Close Price Previous Close
86.69 85.51 86.80 86.63
more quote information »

Recent News

Date Time Source Heading
28/11/202302:31DJNTrending: Sanofi's Notus Trial Meets Primary Endpoint
27/11/202318:40DJNSanofi Says Notus Phase 3 Trial of Dupixent Met Primary..
27/11/202317:30GLOBECommuniqué de presse : Dupixent® a permis de réduire..
24/11/202304:00GLOBESanofi: Informations relatives au nombre de droits de vote..
08/11/202300:56DJNSanofi Under Preliminary Probe in France Over Possible..
30/10/202323:14DJNMeiraGTx Gets $30 Million Investment From Sanofi
28/10/202302:47DJNSanofi Down Over 19%, on Pace for Record Percent Decrease --..
27/10/202319:43DJNSanofi Shares Tumble After Warning of Profit Hit From..
27/10/202317:54DJNSanofi Backs Guidance After Earnings, Sales Miss Views
27/10/202317:35DJNSanofi Plans to Split Consumer-Healthcare, Pharma Businesses..
27/10/202317:07DJNSanofi Plans to Spin Off Consumer-Healthcare Business
27/10/202316:31GLOBECommuniqué de presse : Un troisième trimestre solide, marqué..
27/10/202316:30GLOBECommuniqué de presse : Sanofi entame un nouveau chapitre de..
23/10/202306:00GLOBEPress Release: Dupixent® (dupilumab) Phase 3 Results show..
23/10/202305:59GLOBEDupixent® (dupilumab) Phase 3 Results Show Sustained..
19/10/202321:00GLOBECommuniqué de presse : Sanofi livre les premiers médicaments..
18/10/202320:40DJNSanofi Says Drug Shows Potential to Slow Diabetes in..
18/10/202319:45GLOBEPress Release: TZIELD® Phase 3 data presented at ISPAD shows..
18/10/202305:18GLOBESanofi: Informations relatives au nombre de droits de vote..
14/10/202301:00GLOBECommuniqué de presse : Des données de phase IIb de dernière..
06/10/202317:56DJNSanofi Considering Acquisition of Mirati Therapeutics,..
04/10/202316:57DJNSanofi, Teva Collaborate on Inflammatory Bowel Disease Drug
04/10/202316:00GLOBECommuniqué de presse : Sanofi et Teva annoncent une..
03/10/202317:23DJNSanofi, Janssen Team Up to Develop, Commercialize Vaccine..
03/10/202316:30GLOBEPress Release: Sanofi announces agreement for potential..
26/9/202315:30GLOBECommuniqué de presse : La FDA accorde un examen prioritaire..
26/9/202315:29GLOBEDupixent® (dupilumab) sBLA for Treatment of Eosinophilic..
25/9/202317:00GLOBEPress Release: Once-weekly ALTUVIIIO® approved in Japan as a..
22/9/202316:45DJNSanofi Expects Currency Hit to Sales, Earnings
22/9/202315:30GLOBEPress Release: Availability of the Q3 2023 Memorandum for..
19/9/202316:30GLOBECommuniqué de presse : Sanofi soutient les communautés..
14/9/202321:34DJNFirst Wave BioPharma Shares Surge 82% on License Agreement..
12/9/202304:02GLOBESanofi: Information concerning the total number of voting..
31/8/202315:30GLOBEPress Release: Sanofi announces changes to its Executive..
16/8/202305:24GLOBESanofi: Information concerning the total number of voting..
04/8/202317:17DJNSanofi, AstraZeneca RSV Treatment for Infants Gets U.S. CDC..
04/8/202305:21GLOBEPress Release: U.S. CDC Advisory Committee unanimously..
28/7/202321:22GLOBEPress release: Online availability of Sanofi’s half-year..
28/7/202316:21DJNSanofi Raises 2023 Outlook After 2Q Adjusted Earnings Beat..
28/7/202315:32GLOBECommuniqué de presse : Sanofi va acquérir Qunol®, une marque..
28/7/202315:30GLOBEPress Release: Solid Q2 performance and strong pipeline..
19/7/202302:29GLOBESanofi: Informations relatives au nombre de droits de vote..
18/7/202303:00GLOBECommuniqué de presse : La FDA approuve BeyfortusTM..
29/6/202315:30GLOBECommuniqué de presse : Le pipeline Vaccins de Sanofi relève..
27/6/202315:30GLOBECommuniqué de presse : Amlitelimab : De premières données..
26/6/202316:03DJNSanofi Hemophilia Drug Deemed Safe, Effective in Phase 3..
26/6/202300:30GLOBEPress Release: ALTUVIIIO late-breaking data at ISTH..
22/6/202315:30GLOBECommuniqué de presse : Mise en ligne du document «Q2 2023..
21/6/202303:43GLOBESanofi: Informations relatives au nombre de droits de vote..
20/6/202316:40DJNBoehringer Ingelheim Claim for Indemnification From Sanofi..

Your Recent History

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com